Further processing options
Combination Therapy of a Defucosylated Anti-HM1.24 Monoclonal Antibody Plus Lenalidomide Induces Marked Antibody-Dependent Cellular Cytotoxicity and Inhibits the Clonogenic Potenti...
Saved in:
Journal Title: | Blood |
---|---|
Authors and Corporations: | , , , , , , , , , , , , , , , , , , |
In: | Blood, 120, 2012, 21, p. 1839-1839 |
Type of Resource: | E-Article |
Language: | English |
published: |
American Society of Hematology
|
Subjects: |